Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1971 Jan 31;133(2):353–361. doi: 10.1084/jem.133.2.353

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN

Catalina Fischer-Ferraro 1, Victor E Nahmod 1, Daniel J Goldstein 1, Samuel Finkielman 1
PMCID: PMC2138896  PMID: 4332372

Abstract

An enzyme with the characteristics of classical renin was isolated from brain extracts of nephrectomized dogs. This enzyme is thermolabile, nondialyzable, and forms a vasoconstrictive material when incubated with renin plasma substrate at pH 7. A short lasting pressor activity was also found in brain extracts of dogs and rats. This activity was due to a substance identified by chemical and pharmacological tests as angiotensin. Countercurrent distribution of brain extracts of rats showed that 38% of the pressor activity corresponded to angiotensin II and the remainder to angiotensin I. A remarkable correlation was found between angiotensin and norepinphrine concentrations in different portions of the encephalon of the dog.

Full Text

The Full Text of this article is available as a PDF (455.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett J. D., Sambhi M. P. Simultaneous assay of angiotensin I and II and determination of converting enzyme activity. J Pharmacol Exp Ther. 1969 Dec;170(2):326–333. [PubMed] [Google Scholar]
  2. Boadle M. C., Hughes J., Roth R. H. Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature. 1969 Jun 7;222(5197):987–988. doi: 10.1038/222987a0. [DOI] [PubMed] [Google Scholar]
  3. CARLSSON A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959 Jun;11(2 Pt 2):490–493. [PubMed] [Google Scholar]
  4. DAVIS J. O. The control of aldosterone secretion. Physiologist. 1962 May;5:65–86. [PubMed] [Google Scholar]
  5. Finkielman S., Nahmod V. E. In vitro production of angiotensin I by renal glomeruli. Nature. 1969 Jun 21;222(5199):1186–1188. doi: 10.1038/2221186a0. [DOI] [PubMed] [Google Scholar]
  6. GOULD A. B., SKEGGS L. T., Jr, KAHN J. R. THE PRESENCE OF RENIN ACTIVITY IN BLOOD VESSEL WALLS. J Exp Med. 1964 Mar 1;119:389–399. doi: 10.1084/jem.119.3.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haas E., Goldblatt H., Gipson E. C., Lewis L. Extraction, purification, and assay of human renin free of angiotensinase. Circ Res. 1966 Oct;19(4):739–749. doi: 10.1161/01.res.19.4.739. [DOI] [PubMed] [Google Scholar]
  8. Hayduk K., Boucher R., Genest J. Renin activity content in various tissues od dogs under different physiopathological states. Proc Soc Exp Biol Med. 1970 May;134(1):252–255. doi: 10.3181/00379727-134-34770. [DOI] [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. McCubbin J. W., DeMoura R. S., Page I. H., Olmsted F. Arterial hypertension elicited by subpressor amounts of angiotensin. Science. 1965 Sep 17;149(3690):1394–1395. doi: 10.1126/science.149.3690.1394. [DOI] [PubMed] [Google Scholar]
  11. PEART W. S. THE RENIN-ANGIOTENSIN SYSTEM. Pharmacol Rev. 1965 Jun;17:143–182. [PubMed] [Google Scholar]
  12. Peach M. J., Bumpus F. M., Khairallah P. A. Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther. 1969 Jun;167(2):291–299. [PubMed] [Google Scholar]
  13. Roth M., Weitzman A. F., Piquilloud Y. Converting enzyme content of different tissues of the rat. Experientia. 1969 Dec 15;25(12):1247–1247. doi: 10.1007/BF01897474. [DOI] [PubMed] [Google Scholar]
  14. SCORNIK O. A., PALADINI A. C. Angiotension blood levels in dogs with experimental renal hypertension. Am J Physiol. 1961 Sep;201:526–530. doi: 10.1152/ajplegacy.1961.201.3.526. [DOI] [PubMed] [Google Scholar]
  15. Skeggs L. T., Lentz K. E., Kahn J. R., Dorer F. E., Levine M. Pseudorenin. A new angiotensin-forming enzyme. Circ Res. 1969 Oct;25(4):451–462. doi: 10.1161/01.res.25.4.451. [DOI] [PubMed] [Google Scholar]
  16. Smookler H. H., Severs W. B., Kinnard W. J., Buckley J. P. Centrally mediated cardiovascular effects of angiotensin II. J Pharmacol Exp Ther. 1966 Sep;153(3):485–494. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES